Viatris Inc. (NASDAQ:VTRS) saw its stock drop 3.6% following news that its late-stage trial for MR-139, a potential treatment ...

What Happened? Shares of medication company Viatris (NASDAQ:VTRS) fell 3.8% in the afternoon session after its experimental ...

As summertime family activities are in full swing, simultaneously, so is tick season. And while most tick bites are harmless, ...

To avoid tick bites, wear long-sleeved shirts and long pants, and tuck your pants into your socks to stop ticks from climbing ...

Viatris's said on Friday that the trial of an ointment for people with blepharitis didn't meet its primary endpoint.

The US Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for topical ...

Aldeyra Therapeutics (ALDX) stock in focus as the FDA accepts its resubmitted marketing application for lead drug reproxalap ...

The tool is designed to help with the application of mono-dose, dry eye eyedrop vials more easily and accurately.

GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...

The FDA has accepted for review the second resubmitted NDA for reproxalap for the treatment of the signs and symptoms of dry eye disease.

Microplastics larger than 20 µm appear to be routinely present in commercially available eye drops, according to research published in Cornea. The investigation employed the use of micro-Fourier ...

"Messy bun, morning rituals and that pimple? It’ll catch up later," the Cuttputli actor captioned her Instagram post.